Schedule & Agenda
Monday, June 5
9:00 AM - 12:00 PM
The Department of Defense (DoD) is continuously engaging in efforts to protect the warfighter from…
1:00 PM - 2:00 PM
The pharma industry is facing a wave of loss of exclusivity estimated at $200B through 2026 and an…
Hear from biotech and pharma innovators who have created collaborations to turn technology…
2:15 PM - 3:15 PM
This session will present strategies from CEOs who have secured major financings (AsherBio $108M…
The market volatility in the last 18 months has made it difficult for public biopharmaceutical…
Is this the yearIs this the year that biotech IPO's recover? How do you know when to make the leap?…
3:30 PM - 4:30 PM
In today’s turbulent market backdrop, both life science companies and investors are required to…
We will dive deep into the challenges faced by biotech companies in securing funding, particularly…
This will be a Fireside Chat with Jim Healy at Sofinnova Investments, moderated by Querida Anderson…
How can patient advocacy groups attract an early-stage company to develop technology for their…
Tuesday, June 6
11:00 AM - 12:00 PM
The 33rd edition of EY’s Beyond Borders Biotechnology Report offers a chance to take stock of the…
Over the last decade, there has been an incredible surge in innovation in the life sciences,…
12:15 PM - 1:30 PM
Christopher A. Viehbacher joined Biogen as President and Chief Executive Officer and a member of…
1:45 PM - 2:45 PM
The value of biotech companies can best be described as a discontinuous growth function with…
An aggressive drop in the market and the aftermath of two years of deals via Zoom create a unique…
3:00 PM - 4:00 PM
While the biotech industry has seen record years of venture investment, crossover investments, and…
This panel of top-tier biotech CEOs turned VC investors and advisors will discuss their outlook on…
In the United States, there are two worldclass state-funded and voter approved biomedical research…
3:00 PM - 3:45 PM
Join us for this exciting Fireside Chat with Noubar Afeyan, CEO and Founder of Flagship Pioneering…
4:15 PM - 5:15 PM
Representatives from the Committee on Foreign Investment in the United States (CFIUS) will speak to…
4:15 PM - 4:45 PM
David Thomas, BIO’s Senior Vice President of Industry Analysis, will provide an overview of recent…
Wednesday, June 7
11:00 AM - 12:00 PM
Join us for a special edition of the popular weekly discussion of all things biotech. Reporting…
The pandemic forced support ecosystems for emerging biotechs to adapt their processes to continue…
1:45 PM - 2:45 PM
Despite recent strides in medical innovation – in oncology, COVID-19, neurodegenerative disorders…
3:00 PM - 4:00 PM
This panel will present comparative views of biopharma, investor-backed, and independent incubators…
This session will be based on LHS’ trademarked process of creating corporate narratives and…
4:00 PM - 5:15 PM
Innovation. Which ideas and inventions are likely to serve as the foundation for the creation of…
4:15 PM - 5:15 PM
Early to Mid-Stage Biotechs: Creating Partnerships to Enhance Program Value and Accelerate Therapies
Moderated by Drew Armstrong of Endpoints News, this interactive panel discussion aimed at early to…
What do biotech companies need to consider as they develop their global growth strategy? Companies…
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
.png){kind=logo}
